Lorchel Fabrice, Peignaux Karine, Créhange Gilles, Bosset Mathieu, Puyraveau Marc, Mercier Mariette, Bosset Jean-François, Maingon Philippe
Service d'Oncologie-Radiothérapie, CHU Jean Minjoz, 25030 Besançon Cedex, France.
Gastroenterol Clin Biol. 2007 Apr;31(4):436-41. doi: 10.1016/s0399-8320(07)89407-3.
We performed a retrospective analysis in order to evaluate the compliance with preoperative radiotherapy in patients aged>or=70 with locally advanced resectable rectal cancer, and to evaluate the influence of comorbidities on treatment tolerance and oncological results.
From March 1984 to December 2000, 95 patients with T3-T4 N0 M0 rectal cancer received a preoperative radiotherapy in 2 radiotherapy departments. Nineteen patients received concomitant chemotherapy.
All patients completed the radiation schedule. Six patients suffered grade 3 acute WHO toxicity. Surgical resection was performed in 87 patients. There were 3 post-operative deaths. Analysis of peri-operative complications showed thromboembolism (4.9%), ileus (9.8%) and diarrhoea (6.1%). After a median follow-up of 29 months, the 3- and 5-year overall survival rates were 65% and 49% respectively. In univariate analysis, a tumour located in the mid part of the rectum, a radiation dose less than 40 Gy, the absence of chemotherapy were significantly associated with a poor prognosis. There was a trend to a better survival for patients with a Charlson score of 0 (P=0.0584). In multivariate analysis, only initial WHO performance status was significant.
Compliance with preoperative radiotherapy is good in elderly patients. Toxicity rates are similar to those described in randomised trials in which only younger patients were included. Initial WHO performance status<or=1 is significantly associated with better survival.
我们进行了一项回顾性分析,以评估年龄≥70岁的局部晚期可切除直肠癌患者术前放疗的依从性,并评估合并症对治疗耐受性和肿瘤学结果的影响。
1984年3月至2000年12月,95例T3 - T4 N0 M0直肠癌患者在2个放疗科室接受了术前放疗。19例患者接受了同步化疗。
所有患者均完成了放疗计划。6例患者出现3级急性世界卫生组织(WHO)毒性反应。87例患者进行了手术切除。有3例术后死亡。围手术期并发症分析显示血栓栓塞(4.9%)、肠梗阻(9.8%)和腹泻(6.1%)。中位随访29个月后,3年和5年总生存率分别为65%和49%。单因素分析中,肿瘤位于直肠中部、放疗剂量小于40 Gy、未进行化疗与预后不良显著相关。Charlson评分为0的患者有生存更好的趋势(P = 0.0584)。多因素分析中,仅初始WHO体能状态具有显著性。
老年患者术前放疗的依从性良好。毒性发生率与仅纳入年轻患者的随机试验中所描述的相似。初始WHO体能状态≤1与更好的生存显著相关。